Investments
61Portfolio Exits
15Funds
7About Longwood Fund
Longwood Fund is a healthcare venture capital firm that founds, manages, and builds healthcare companies. Longwood's mission is to identify technologies and to found companies that will advance new therapeutics that can not only make a difference in the lives of patients worldwide, but also create significant value for investors. This is achieved by leveraging the management team's history of successful healthcare company formation and operational leadership.
Want to inform investors similar to Longwood Fund about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing Longwood Fund
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Longwood Fund in 1 Expert Collection, including Vitamin & Supplement Startups.
Vitamin & Supplement Startups
237 items
Latest Longwood Fund News
Sep 15, 2023
News Reporter Phil Vickers started last week as president and CEO of Solu Therapeutics, a Longwood Fund startup developing small molecule-antibody chimeras. He takes the place of Longwood executive partner David Donabedian, who has taken the early CEO roles at a number of companies Longwood has backed, including Axial Therapeutics, ImmuneID and DEM BioPharma. Vickers was previously head of Faze Medicines, a condensates biotech started by Third Rock that launched with $81 million in 2020 before shutting down at the end of last year . Unlock this article instantly by becoming a free subscriber. You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news. SIGN UP
Longwood Fund Investments
61 Investments
Longwood Fund has made 61 investments. Their latest investment was in Solu Therapeutics as part of their Seed VC on August 8, 2023.
Longwood Fund Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
8/1/2023 | Seed VC | Solu Therapeutics | $31M | Yes | 1 | |
6/6/2023 | Series A | AAVantgarde Bio | $65.1M | Yes | 3 | |
2/24/2023 | Unattributed VC | CoLabs | $0.32M | Yes | 2 | |
12/6/2022 | Series C - II | |||||
9/20/2022 | Series A |
Date | 8/1/2023 | 6/6/2023 | 2/24/2023 | 12/6/2022 | 9/20/2022 |
|---|---|---|---|---|---|
Round | Seed VC | Series A | Unattributed VC | Series C - II | Series A |
Company | Solu Therapeutics | AAVantgarde Bio | CoLabs | ||
Amount | $31M | $65.1M | $0.32M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 1 | 3 | 2 |
Longwood Fund Portfolio Exits
15 Portfolio Exits
Longwood Fund has 15 portfolio exits. Their latest portfolio exit was Pyxis Oncology on October 08, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
10/8/2021 | IPO | Public | 9 | ||
7/16/2021 | IPO | Public | 4 | ||
4/30/2021 | IPO | Public | 5 | ||
Date | 10/8/2021 | 7/16/2021 | 4/30/2021 | ||
|---|---|---|---|---|---|
Exit | IPO | IPO | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | Public | Public | ||
Sources | 9 | 4 | 5 |
Longwood Fund Fund History
7 Fund Histories
Longwood Fund has 7 funds, including Longwood Fund VI.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
5/5/2023 | Longwood Fund VI | $180M | 3 | ||
7/23/2020 | Longwood Fund V | ||||
12/31/2016 | Longwood Fund IV | ||||
12/31/2015 | Longwood Fund III | ||||
5/15/2014 | Longwood Fund II |
Closing Date | 5/5/2023 | 7/23/2020 | 12/31/2016 | 12/31/2015 | 5/15/2014 |
|---|---|---|---|---|---|
Fund | Longwood Fund VI | Longwood Fund V | Longwood Fund IV | Longwood Fund III | Longwood Fund II |
Fund Type | |||||
Status | |||||
Amount | $180M | ||||
Sources | 3 |
Longwood Fund Team
3 Team Members
Longwood Fund has 3 team members, including , .
Name | Work History | Title | Status |
|---|---|---|---|
Rich Aldrich | Founder | Current | |
Name | Rich Aldrich | ||
|---|---|---|---|
Work History | |||
Title | Founder | ||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
